Heron Patrick J
Insider CIK 1365617 · GKOS 10% owner · COLL Director, 10% owner · TBRA Director · ANAB 10% owner · CDTX Director · IMGO Director · ALPN 10% owner · PCVX Director · ITRM Director, 10% owner · APTX 10% owner · ETTX 10% owner · MIRM Director, 10% owner · MBX Director, 10% owner · PHAT 10% owner · PASG Director, 10% owner · ARQT Director, 10% owner · TARS 10% owner · FLAC Director · HLVX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 1,980 | — | $0 | 1,980 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 3,772 | — | $0 | 3,772 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-06-05 | 2026-06-09 | 16,667 | — | $0 | 16,667 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2026-06-05 | 2026-06-09 | 5,778 | — | $0 | 32,213 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2026-01-23 | 2026-01-27 | 131,425 | $68.48 | $9.00M | 459,010 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2026-01-23 | 2026-01-27 | 159,277 | — | $0 | 327,585 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-09-26 | 2025-09-30 | 666,666 | $18.00 | $12.00M | 5,219,440 | SEC↗ |
| HLVX HilleVax, Inc. | U Tender | 2025-09-17 | 2025-09-17 | 17,199 | $1.95 | $33.5K | 0 | SEC↗ |
| HLVX HilleVax, Inc. | U Tender | 2025-09-17 | 2025-09-17 | 8,535,337 | $1.95 | $16.64M | 0 | SEC↗ |
| HLVX HilleVax, Inc. | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 17,199 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-06-13 | 2025-06-17 | 2,646 | $13.08 | $34.6K | 27,448 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-06-12 | 2025-06-16 | 20,568 | — | $0 | 20,568 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-06-12 | 2025-06-16 | 7,609 | — | $0 | 26,435 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-06-05 | 2025-06-06 | 378 | $13.41 | $5.1K | 24,802 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-06-04 | 2025-06-06 | 1,890 | $13.32 | $25.2K | 24,424 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-05-29 | 2025-06-02 | 5,703 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 3,977 | — | $0 | 3,977 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 6,268 | — | $0 | 6,268 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-05-29 | 2025-06-02 | 5,703 | — | $0 | 5,703 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-05-22 | 2025-05-23 | 2,520 | $13.65 | $34.4K | 22,534 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-05-21 | 2025-05-23 | 2,520 | $13.66 | $34.4K | 20,014 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-05-15 | 2025-05-19 | 2,520 | $13.62 | $34.3K | 17,494 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-05-14 | 2025-05-15 | 6,300 | $13.76 | $86.7K | 14,974 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-05-13 | 2025-05-15 | 2,374 | $13.76 | $32.7K | 8,674 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2025-05-09 | 2025-05-13 | 6,300 | $13.60 | $85.7K | 6,300 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-17 | 2025-03-18 | 21 | $43.93 | $923 | 168,672 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-14 | 2025-03-18 | 528 | $44.11 | $23.3K | 168,651 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-11 | 2025-03-12 | 963 | $43.77 | $42.2K | 168,123 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-10 | 2025-03-12 | 758 | $42.66 | $32.3K | 166,583 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-10 | 2025-03-12 | 577 | $43.37 | $25.0K | 167,160 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-07 | 2025-03-10 | 580 | $43.21 | $25.1K | 165,825 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-06 | 2025-03-10 | 1,335 | $43.89 | $58.6K | 165,245 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-05 | 2025-03-06 | 267 | $44.55 | $11.9K | 163,910 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-04 | 2025-03-06 | 56 | $45.96 | $2.6K | 163,643 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2025-03-04 | 2025-03-06 | 1,279 | $45.55 | $58.3K | 163,587 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2024-09-18 | 2024-09-20 | 115 | $37.40 | $4.3K | 162,308 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 18,922,852 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 28,297,265 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 3,927,774 | — | $0 | 3,927,774 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 625,000 | $16.00 | $10.00M | 4,552,774 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2024-09-06 | 2024-09-10 | 230 | $41.58 | $9.6K | 162,193 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-06-14 | 2024-06-18 | 27,052 | — | $0 | 27,052 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-06-14 | 2024-06-18 | 10,139 | — | $0 | 18,826 | SEC↗ |
| HLVX HilleVax, Inc. | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 5,703 | — | $0 | 5,703 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 8,779 | — | $0 | 8,779 | SEC↗ |
| HLVX HilleVax, Inc. | P Buy | 2024-04-04 | 2024-04-08 | 8,850 | $14.50 | $128.3K | 8,544,187 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2024-03-04 | 2024-03-06 | 21,052 | $9.50 | $200.0K | 8,785,284 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2023-11-09 | 2023-11-14 | 2,910 | $28.30 | $82.4K | 161,963 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2023-10-24 | 2023-10-26 | 80,000 | $2.50 | $200.0K | 8,764,232 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2023-09-13 | 2023-09-15 | 2,625 | $31.02 | $81.4K | 159,053 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2023-09-12 | 2023-09-13 | 3,750 | $30.60 | $114.8K | 156,428 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2023-09-11 | 2023-09-13 | 4,687 | $30.30 | $142.0K | 152,678 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2023-08-31 | 2023-09-05 | 147,991 | $26.25 | $3.88M | 147,991 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| HLVX HilleVax, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-05-31 | 2023-06-02 | 12,220 | — | $0 | 12,220 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-05-31 | 2023-06-02 | 4,375 | — | $0 | 8,687 | SEC↗ |
| HLVX HilleVax, Inc. | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2022-08-05 | 2022-08-09 | 250,000 | $20.00 | $5.00M | 8,684,232 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-06-02 | 2022-06-06 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2022-06-01 | 2022-06-03 | 11,796 | — | $0 | 11,796 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2022-06-01 | 2022-06-03 | 4,312 | — | $0 | 4,312 | SEC↗ |
| HLVX HilleVax, Inc. | C Conversion deriv | 2022-05-03 | 2022-05-03 | 37,212,796 | — | $0 | 0 | SEC↗ |
| HLVX HilleVax, Inc. | P Buy | 2022-05-03 | 2022-05-03 | 1,764,706 | $17.00 | $30.00M | 8,535,337 | SEC↗ |
| HLVX HilleVax, Inc. | C Conversion | 2022-05-03 | 2022-05-03 | 2,736,234 | $13.60 | $37.21M | 6,770,631 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2022-02-11 | 2022-02-15 | 112,665 | $7.10 | $799.9K | 1,484,115 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2021-09-17 | 2021-09-21 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer | 2021-09-17 | 2021-09-21 | 1,200,000 | — | $0 | 1,371,450 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 64,360 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 225,850 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 740,673 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,199,890 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 211,069 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 341,932 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 145,918 | $16.00 | $2.33M | 145,918 | SEC↗ |
| IMGO Imago BioSciences, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 41,582 | $16.00 | $665.3K | 41,582 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 64,360 | — | $0 | 658,943 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 211,069 | — | $0 | 594,583 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 225,850 | — | $0 | 2,312,331 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 740,673 | — | $0 | 2,086,481 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 1,199,890 | — | $0 | 1,345,808 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 341,932 | — | $0 | 383,514 | SEC↗ |
| IMGO Imago BioSciences, Inc. | A Award deriv | 2021-07-15 | 2021-07-19 | 23,809 | — | $0 | 23,809 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2021-06-09 | 2021-06-11 | 13,391 | — | $0 | 13,391 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-06-04 | 2021-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | J Other | 2021-05-10 | 2021-05-12 | 96,574 | — | $0 | 96,574 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | J Other | 2021-05-10 | 2021-05-12 | 96,574 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | J Other | 2021-05-10 | 2021-05-12 | 2,108,558 | — | $0 | 8,434,232 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | A Award deriv | 2020-12-11 | 2020-12-11 | 333,333 | — | $0 | 333,333 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | A Award deriv | 2020-12-11 | 2020-12-11 | 167,000 | — | $0 | 167,000 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | A Award | 2020-12-11 | 2020-12-11 | 501,000 | $10.00 | $5.01M | 501,000 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | P Buy | 2020-12-11 | 2020-12-11 | 1,000,000 | $10.00 | $10.00M | 1,000,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 214,281 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,390,376 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | P Buy | 2020-10-20 | 2020-10-20 | 312,500 | $16.00 | $5.00M | 1,917,157 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 214,281 | — | $0 | 1,604,657 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 1,390,376 | — | $0 | 1,390,376 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2020-07-01 | 2020-07-06 | 2,852 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2020-07-01 | 2020-07-06 | 2,852 | — | $0 | 9,006 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 1,692,494 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 226,236 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 140,824 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 1,692,494 | — | $0 | 1,692,494 | SEC↗ |
| PCVX Vaxcyte, Inc. | P Buy | 2020-06-16 | 2020-06-16 | 250,000 | $16.00 | $4.00M | 2,309,554 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 226,236 | — | $0 | 1,918,730 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 140,824 | — | $0 | 2,059,554 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | J Other | 2020-06-12 | 2020-06-16 | 1,456,854 | — | $0 | 5,827,415 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-15 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-03 | 432,802 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-03 | 1,049,175 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-03 | 2,977,242 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-03 | 2,977,242 | — | $0 | 2,977,242 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-03 | 1,049,175 | — | $0 | 4,026,417 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-03 | 432,802 | — | $0 | 4,459,219 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-03 | 550,000 | $18.00 | $9.90M | 5,009,219 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 33,836 | — | $0 | 33,836 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2020-02-27 | 2020-03-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 2,099,019 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 6,360,272 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 1,074,467 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-04 | 2020-02-06 | 500,000 | $17.00 | $8.50M | 10,542,790 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 6,360,272 | — | $0 | 6,869,304 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 2,099,019 | — | $0 | 8,968,323 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 1,074,467 | — | $0 | 10,042,790 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $333000.00 | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $1167000.00 | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | S Sale | 2020-01-09 | 2020-01-13 | 50,000 | $5.00 | $250.0K | 1,299,953 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | C Conversion deriv | 2019-10-29 | 2019-10-30 | 0 | — | $0 | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | C Conversion | 2019-10-29 | 2019-10-30 | 1,353,640 | $15.20 | $20.58M | 6,231,638 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | P Buy | 2019-10-29 | 2019-10-30 | 1,052,631 | $19.00 | $20.00M | 7,284,269 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 24,935,300 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 3,566,912 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,116,912 | — | $0 | 3,116,912 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 2,852 | — | $0 | 2,852 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 9,836 | — | $0 | 9,836 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy deriv | 2019-01-18 | 2019-01-22 | 145,251 | — | $0 | 145,251 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2019-01-18 | 2019-01-22 | 372,439 | $5.37 | $2.00M | 2,571,450 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,000,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 5,212,833 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 6,651,574 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 320,898 | — | $0 | 974,066 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 251,487 | — | $0 | 589,194 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 337,707 | — | $0 | 337,707 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 375,887 | $15.00 | $5.64M | 1,349,953 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 21,946,301 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 28,895,188 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 33,022,786 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,197,076 | — | $0 | 2,244,526 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 795,553 | — | $0 | 3,040,079 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,047,450 | — | $0 | 1,047,450 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 150,000 | $16.00 | $2.40M | 3,190,079 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 141,166 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 495,370 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 44,940 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 53,899 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 157,701 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 189,141 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 53,899 | — | $0 | 195,065 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 141,166 | — | $0 | 141,166 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 157,701 | — | $0 | 842,212 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 189,141 | — | $0 | 684,511 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 495,370 | — | $0 | 495,370 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 44,940 | — | $0 | 240,005 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 101,150 | $13.00 | $1.31M | 341,155 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 354,949 | $13.00 | $4.61M | 1,197,161 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| ANAB ANAPTYSBIO INC | J Other | 2018-05-11 | 2018-05-15 | 1,372,000 | — | $0 | 973,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | J Other | 2018-05-11 | 2018-05-15 | 1,372,000 | — | $0 | 973,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise deriv | 2017-02-02 | 2017-02-06 | 117,235 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise deriv | 2017-02-02 | 2017-02-06 | 117,235 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise | 2017-02-02 | 2017-02-06 | 117,235 | $4.55 | $533.4K | 2,345,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise | 2017-02-02 | 2017-02-06 | 117,235 | $4.55 | $533.4K | 2,345,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 311,291 | $15.00 | $4.67M | 311,291 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 209,095 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 195,751 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 604,055 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 1,428,571 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 88,709 | $15.00 | $1.33M | 88,709 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 733,740 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 733,740 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 195,751 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 209,095 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 311,291 | $15.00 | $4.67M | 311,291 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 88,709 | $15.00 | $1.33M | 88,709 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 1,428,571 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 604,055 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 15,500 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 4,332 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,778 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 17,778 | — | $0 | 17,778 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2015-09-10 | 2015-09-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-07-09 | 2015-07-13 | 15,500 | — | $0 | 15,500 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 151,653 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 253,390 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,523,809 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 674,510 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,603,362 | — | $0 | 2,603,362 | SEC↗ |
| GKOS GLAUKOS Corp | X Exercise deriv | 2015-06-26 | 2015-06-30 | 24,705 | $7.65 | $189.0K | 674,510 | SEC↗ |
| GKOS GLAUKOS Corp | X Exercise deriv | 2015-06-26 | 2015-06-30 | 24,705 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,019,183 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 2,705,585 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,676,078 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,533,399 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 582,490 | — | $0 | 582,490 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 222,231 | — | $0 | 804,721 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 392,113 | — | $0 | 1,196,834 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 540,498 | — | $0 | 1,737,332 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-14 | 150,000 | $12.00 | $1.80M | 1,887,332 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 4,332 | — | $0 | 4,332 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award | 2015-05-04 | 2015-05-06 | 2,668,570 | — | $0 | 2,668,570 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | C Conversion deriv | 2015-04-20 | 2015-04-22 | 865,590 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | C Conversion deriv | 2015-04-20 | 2015-04-22 | 246,668 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2015-04-20 | 2015-04-22 | 155,645 | $16.00 | $2.49M | 155,645 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | C Conversion | 2015-04-20 | 2015-04-22 | 246,668 | — | $0 | 291,023 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2015-04-20 | 2015-04-22 | 44,355 | $16.00 | $709.7K | 44,355 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | C Conversion | 2015-04-20 | 2015-04-22 | 865,590 | — | $0 | 1,021,235 | SEC↗ |